ACTR-33. A PHASE I DOSE ESCALATION AND CENTRAL NERVOUS SYSTEM (CNS) PHARMACOKINETIC STUDY OF PULSATILE AFATINIB IN PATIENTS WITH BRAIN CANCER

Patients with primary brain cancer or brain metastases represent a population with a large unmet medical need. The critical premise behind our investigation into pulse dosing of growth factor inhibitors for brain cancer is that current treatment is limited by drug penetration into the central nervou...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Juarez, Tiffany, Boucher, Najee, Heng, Annie, Gill, Jaya, Nguyen, Minhdan, Truong, Judy, Saria, Marlon, Achrol, Achal, Barkhoudarian, Garni, Kelly, Daniel, Kesari, Santosh
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2017
Matèries:
Abstracts
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692747/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.026
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars